![]() |
市场调查报告书
商品编码
1679243
2030 年单细胞油市场预测:按微生物、等级、原料、应用和地区进行的全球分析Single Cell Oil Market Forecasts to 2030 - Global Analysis By Micro-Organisms (Bacteria, Yeast, Microalgae and Fungal), Grade (Fuel Grade, Feed Grade and Food Grade), Raw Material, Application and By Geography |
根据 Stratistics MRC 的数据,2024 年全球单细胞油市场价值为 6,855 万美元,预计到 2030 年将达到 2.084 亿美元,预测期内的复合年增长率为 20.36%。
由酵母、真菌和藻类等微生物培养而产生的油称为单细胞油(SCO)。这些微生物油是传统植物油和动物油的环保替代品,具有生产速度快、脂肪酸组成适应性强、水和土地消耗少等优点。 SCO 富含Omega-3和Omega-6脂肪酸,可用于食品、饲料、製药和生质燃料应用。
根据国际能源总署(IEA)的数据,2021年生质燃料将占全球运输能源需求的3.6%左右,主要用于道路运输。在净零情境下,到 2030 年生质燃料对运输的贡献预计将增加四倍,达到 15%,相当于道路运输总燃料需求的近五分之一。
人们对永续石油的兴趣日益浓厚
人们对环境永续性的认识不断提高,加上传统石油开采造成的森林砍伐、栖息地破坏和温室气体排放,加速了对替代脂质来源的寻找。单细胞油(SCO)由藻类、真菌和酵母等微生物生产,被视为鱼油、大豆油和棕榈油的有前途的替代品,因为生产它们需要更少的土地和水。食品、化妆品和製药业正在研究 SCO 作为永续的替代品,因为它可以生产高价值的脂质,而不会产生与传统脂肪和油源相关的环境问题。
商业规模生产有限
即使采用目前的技术进步,扩大单细胞油的生产仍然极为困难。维持理想的生长条件、确保稳定的脂质积累、以及在不牺牲产量或品质的情况下有效提取油是阻碍从实验室生产转变为工业规模生产的一些挑战。许多微生物需要精心调节的发酵条件,包括温度、pH 值和营养物质的利用率,这增加了大规模生产的复杂性。此外,干燥、榨油和细胞收穫等下游工序仍成本高昂且耗能。
人们对替代石油和永续石油的兴趣日益浓厚
人们对棕榈油和大豆油等传统油类的环境问题的担忧日益加剧,推动了对永续替代品的需求。单细胞油(SCO)由细菌、真菌和微藻类製成,是一种环保替代品,因为生产它不需要大量土地或砍伐森林。在食品、化妆品和工业应用中,对于寻求环保和永续脂质来源的产业来说,SCO 已成为棕榈油和其他植物油的可行替代品。此外,SCO 的适应性脂肪酸组成使其适用于需要特定脂质特性的应用,从而增强了其在国际市场的吸引力。
来自传统油脂的激烈竞争
全球食用油脂市场主要由棕榈油、大豆油和鱼油等低成本、广泛供应的油类主导。由于产业联繫、规模经济和已建立的供应链,这些石油很难被取代。此外,SCO 对大多数製造商和消费者来说仍然相对较新且未知,而传统油则拥有成熟的基本客群。为了与现有企业竞争,单细胞油必须展现出卓越的功能性和成本效益,即使在生质燃料、食品强化和Omega-3补充剂等利基市场。此外,如果没有明显的价格优势或独特优势,SCO 的采用可能仍将局限于专门的应用领域。
COVID-19 疫情影响了许多行业的供应链、生产和需求动态,也以各种方式影响了单细胞油 (SCO) 市场。最初,SCO的生产和分销受到劳动力短缺、全球供应链中断和原材料短缺的影响,导致生产延迟和成本增加。然而,疫情增加了消费者对增强免疫力的补充剂、营养保健食品和机能性食品的需求,并引发了人们对富含Omega-3脂肪酸(DHA 和 EPA)的 SCO 作为鱼油永续替代品的兴趣。
预计预测期内微藻类部分将成为最大的部分。
预计微藻类将在预测期内占据最大的市场占有率,因为它具有高脂质含量、优质的Omega-3脂肪酸组成(DHA 和 EPA),并且广泛应用于食品、膳食补充剂和水产养殖。微藻类油是一种永续的、适合素食者的鱼油和磷虾油替代品,在动物饲料、营养补充剂和机能性食品中越来越受欢迎。对永续植物来源脂质源的需求不断增长以及生物加工和大规模藻类培养市场的发展进一步增强了市场主导地位。此外,政府对生物基解决方案的倡议和投资也加速了研究和商业性应用,进一步巩固了微藻类在 SCO 市场中的领先地位。
预计鱼油替代品市场在预测期内将实现最高复合年增长率
由于食品、膳食补充剂和水产养殖中对永续植物来源的Omega-3 的需求不断增加,预计鱼油替代品领域将在预测期内呈现最高增长率。由于担心过度捕捞、海洋污染和鱼油供应减少,业界积极寻找富含 DHA 和 EPA 的替代脂质来源,基于微藻类的 SCO 是一种受欢迎的选择。素食和纯素饮食日益流行,以及人们对道德采购和环境永续性的认识不断提高,也推动了需求。此外,大规模藻类培养和微生物发酵的发展使得生产更加经济高效,使SCO成为水产饲料、营养保健品和机能性食品等各领域传统鱼油的有竞争力的替代品。
由于对生物技术和永续脂质生产的大量投资,以及消费者对植物来源Omega-3补充剂、营养保健品和机能性食品的强劲需求,市场占有率。该地区的食品和营养补充剂行业已经很成熟,纯素和替代油比传统鱼油和植物油越来越受欢迎。由于政府对生物基产业的支持、微生物发酵市场的发展以及 DSM、Corbion 和 Cargill 等主要参与者的大力研发,市场也在不断增长。此外,随着SCO在生质燃料、药品和水产饲料领域的应用日益广泛,北美的市场力量也进一步增强。
预计预测期内欧洲地区将呈现最高的复合年增长率。这是由严格的永续性法、对植物替代品日益增长的需求以及生物技术的突破所推动的。随着该地区致力于减少对传统鱼类和植物油的依赖,基于微藻类的 SCO 在机能性食品、药品和水产养殖中的应用越来越频繁。德国、法国和英国等国家在生物技术研究和基于发酵的脂质生产方面处于领先地位,这进一步支持了市场的扩张。此外,随着消费者对素食和永续的Omega-3来源的认识不断提高,以及政府对生物基工业和再生能源来源的激励措施,SCO 在食品、饲料和生质燃料的应用正在欧洲加速扩展。
According to Stratistics MRC, the Global Single Cell Oil Market is accounted for $68.55 million in 2024 and is expected to reach $208.40 million by 2030 growing at a CAGR of 20.36% during the forecast period. Oils made from microorganisms like yeast, fungus, and algae that are grown for their capacity to produce valuable lipids are referred to as single cell oil (SCO). These microbial oils are environmentally friendly substitutes for conventional plant and animal-based oils, with benefits like quick production, adaptable fatty acid composition, and low water and land consumption. SCOs are useful in food, feed, medicine, and bio fuel applications because they are especially high in omega-3 and omega-6 fatty acids.
According to the International Energy Agency (IEA), biofuels represented approximately 3.6% of the global transport energy demand in 2021, primarily for road transport. Under the Net Zero Scenario, the contribution of biofuels to transport is likely to quadruple to 15% by 2030, amounting to almost one-fifth of the total fuel demand for road transport alone.
Growing interest in sustainable oils
The hunt for alternative lipid sources has accelerated due to growing environmental sustainability consciousness and deforestation, habitat destruction, and greenhouse gas emissions caused by conventional oil extraction. Because single cell oils (SCOs), which are made from microorganisms like algae, fungi, and yeast, require less land and water than fish, soybean, or palm oils, they present a promising alternative. The food, cosmetic, and pharmaceutical industries are among those investigating SCO as a sustainable substitute due to its capacity to generate high-value lipids without the environmental problems associated with conventional oil sources.
Limited production on a commercial scale
Scaling up single-cell oil production is still very difficult, even with advances in technology. Keeping ideal growth conditions, guaranteeing steady lipid accumulation, and effectively extracting the oils without sacrificing yield or quality are some of the challenges that impede the shift from laboratory-scale to industrial-scale production. The complexity of large-scale production is increased by the fact that many microorganisms require carefully regulated fermentation conditions, such as temperature, pH, and nutrient availability. Additionally, downstream processing-this includes drying, oil extraction, and cell harvesting-remains costly and energy-intensive.
Growing interest in alternative and sustainable oils
The increasing environmental concerns surrounding conventional oils like palm and soybean oil have driven demand for sustainable alternatives. Single-cell oils (SCOs), which are made from bacteria, fungi, and microalgae, offer an environmentally friendly alternative because they can be made without requiring a lot of land or deforestation. In food, cosmetics, and industrial applications, SCOs have become viable alternatives to palm oil and other vegetable oils as industries look for environmentally friendly, sustainable lipid sources. Furthermore, they are also appropriate for applications that call for particular lipid profiles due to their adaptable fatty acid compositions, which increase their appeal on the international market.
Significant competition from traditional oils
The global edible oil and lipid markets are dominated by low-cost, widely available oils such as palm oil, soybean oil, and fish oil. These oils are hard to replace because of their established industry relationships, economies of scale, and well-established supply chains. Furthermore, while SCOs are still relatively new and unknown to the majority of manufacturers and consumers, traditional oils have a well-established customer base. To compete with current products, single-cell oils must demonstrate their superior functionality and cost-effectiveness, even in niche markets like biofuels, food fortification, and omega-3 supplements. Moreover, adoption of SCO may continue to be restricted to specialized applications in the absence of distinct price advantages or unique benefits.
The COVID-19 pandemic affected supply chains, production, and demand dynamics in a number of industries, with varying effects on the single cell oil (SCO) market. At first, SCO production and distribution were impacted by labor shortages, global supply chain disruptions, and raw material shortages, which resulted in delays and higher expenses. The pandemic did, however, also increase consumer demand for immune-boosting supplements, nutraceutical, and functional foods, which sparked interest in SCOs high in omega-3 fatty acids (DHA & EPA) as sustainable substitutes for fish oil.
The Microalgae segment is expected to be the largest during the forecast period
The Microalgae segment is expected to account for the largest market share during the forecast period due to its high lipid content, superior omega-3 fatty acid composition (DHA & EPA), and extensive use in food, nutraceuticals, and aquaculture. Microalgae-based oils are a sustainable and vegan-friendly substitute for fish and krill oil, increasing their popularity in animal feed, dietary supplements, and functional foods. The market's dominance has been further bolstered by the growing demand for plant-based and sustainable lipid sources, as well as by developments in bioprocessing and large-scale algal cultivation. Furthermore, government initiatives and investments in bio-based solutions have also accelerated research and commercial adoption, further solidifying microalgae's position as a leader in the SCO market.
The Fish Oil Substitute segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Fish Oil Substitute segment is predicted to witness the highest growth rate, driven by the rising demand for sustainable, plant-based omega-3 sources in food, nutraceuticals, and aquaculture. Microalgae-based SCOs are a popular option because industries are actively looking for alternative lipid sources rich in DHA and EPA due to worries about overfishing, marine pollution, and diminishing fish oil supplies. Demand is also being fueled by the growing popularity of vegetarian and vegan diets as well as heightened awareness of ethical sourcing and environmental sustainability. Moreover, developments in large-scale algal cultivation and microbial fermentation are increasing the cost-effectiveness and efficiency of production, making SCOs a competitive alternative to conventional fish oil in a variety of sectors, such as aquafeed, dietary supplements, and functional foods.
During the forecast period, the North America region is expected to hold the largest market share, driven by substantial investments in biotechnology and sustainable lipid production, as well as the strong consumer demand for plant-based omega-3 supplements, nutraceuticals, and functional foods. The food and dietary supplement industries in the area are well-established, and vegan and alternative oils are becoming more and more popular than conventional fish and vegetable oils. The market is also growing as a result of government support for bio-based industries, developments in microbial fermentation, and robust R&D efforts by major players like DSM, Corbion, and Cargill. Additionally, North America's market dominance is further cemented by the growing use of SCOs in biofuels, pharmaceuticals, and aquaculture feed.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by stringent sustainability laws, growing demand for plant-based substitutes, and biotechnology breakthroughs. Because of the region's strong emphasis on lowering dependency on conventional fish and vegetable oils, microalgae-based SCOs are being used more frequently in functional foods, pharmaceuticals, and aquaculture. Market expansion is further supported by the fact that nations like Germany, France, and the UK are at the forefront of biotechnology research and fermentation-based lipid production. Furthermore, the expansion of SCO applications in food, feed, and biofuels in Europe is being accelerated by growing consumer awareness of vegan and sustainable omega-3 sources, as well as government incentives for bio-based industries and renewable energy sources.
Key players in the market
Some of the key players in Single Cell Oil market include Alltech Biotechnology Pvt. LTD, Hubei Xinhe Biotechnology Co. Ltd., Novozymes A/S, Royal DSM NV, Corbion N.V., Archer Daniels Midland (ADM), Cellana Inc, Goerlich Pharma GmbH, Evonik Industries AG, Cargill Incorporated, Xiamen Huison Biotech Co.Ltd., Bioriginal Food & Science Corp., Chevron Corporation, Omega Protein Corporation and TerraVia Holdings, Inc.
In April 2024, Corbion and Kingswood Capital Management, LP ("Kingswood"), a middle-market private equity firm with significant experience in corporate carve-outs have completed the earlier announced sale of Corbion's emulsifiers business. Kingswood acquired the emulsifier business from Corbion for a cash purchase price of $362M, with expected net cash proceeds of approximately $275M, post tax and transaction costs.
In December 2023, ADM announced that it has reached an agreement to acquire UK-based FDL, a leading developer and producer of premium flavor and functional ingredient systems. FDL, with projected 2023 sales of approximately $120 million, operates three production facilities and two customer innovation centers, all in the United Kingdom.
In December 2022, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.